Your session is about to expire
← Back to Search
Non-invasive Brain Stimulation
Non-Invasive Brain Stimulation for Working Memory Improvement
N/A
Recruiting
Led By Alexander Opitz, PhD
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
The patient has or is scheduled for surgically implanted electrodes for the purposes of phase II epilepsy surgical evaluation
Age 18+ years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediate effect during stimulation
Awards & highlights
Study Summary
This trial will test whether tACS can improve working memory and brain connectivity in people with epilepsy.
Who is the study for?
This trial is for adults over 18 who can give their own consent and are undergoing phase II epilepsy surgical evaluation with implanted electrodes. It's not suitable for those unable to consent.Check my eligibility
What is being tested?
The study tests if a non-invasive brain stimulation technique, called traveling wave transcranial alternating current stimulation (tACS), can improve working memory and alter brain connectivity in epilepsy patients.See study design
What are the potential side effects?
Potential side effects of tACS may include mild headaches, scalp tingling, lightheadedness, or discomfort at the electrode sites during stimulation.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have or will have electrodes implanted for epilepsy surgery evaluation.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ immediate effect during stimulation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediate effect during stimulation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Electrophysiological outcomes
Working memory outcomes
Trial Design
2Treatment groups
Experimental Treatment
Group I: Stimulation Theta GroupExperimental Treatment1 Intervention
Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 4 Hz (theta condition).
Group II: Stimulation Beta GroupExperimental Treatment1 Intervention
Participants will experience traveling wave transcranial alternating current stimulation over the fronto-parietal regions at 23 Hz (beta condition).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial alternating current stimulation
2021
N/A
~140
Find a Location
Who is running the clinical trial?
University of MinnesotaLead Sponsor
1,380 Previous Clinical Trials
1,588,729 Total Patients Enrolled
1 Trials studying Working Memory
24 Patients Enrolled for Working Memory
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,751 Total Patients Enrolled
2 Trials studying Working Memory
80 Patients Enrolled for Working Memory
Alexander Opitz, PhDPrincipal InvestigatorUniversity of Minnesota
3 Previous Clinical Trials
138 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have or will have electrodes implanted for epilepsy surgery evaluation.I have difficulty understanding and making health decisions.I am 18 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Stimulation Theta Group
- Group 2: Stimulation Beta Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are any enrolment slots available for this clinical investigation?
"Clinicialtrials.gov reveals that this research endeavour is recruiting participants, with the trial being initially announced on November 1st 2020 and most recently updated on January 27th 2022."
Answered by AI
How many people may take part in this research initiative?
"Yes, the details on clinicaltrials.gov demonstrate that this is a currently running experiment. It was initially advertised on November 1st 2020 and revised as recently as January 27th 2022; seeking 16 individuals to enroll at one medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger